Citations

Mayo Clinic

Showing 10 of 108599 citations.

Coronary calcium quantification using contrast‐enhanced dual‐energy computed tomography scans
Yamak, Didem, Pavlicek, William , Boltz, Thomas, Panse, Prasad M., Akay, Metin

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 14 | Issue: 3 | Pages: 203-214

10.1120/jacmp.v14i3.4014 | PMID 23652239 Get It

The purpose of this study is to evaluate a direct measure of calcium burden by using dual‐energy computed tomography (DECT) during contrast‐enhanced coronary imaging, potentially eliminating the need for an extra noncontrast X‐ray acquisition. The ambiguity of separation of calcium from contrast material on contrast‐enhanced images was solved by using virtual noncontrast images obtained by DECT. A new threshold CT number was required to detect the calcium carrying potential risk for adverse coronary events on virtual noncontrast images. Two methods were investigated to determine the 130 HU threshold for DECT scoring. An in vitro anthropomorphic phantom with 29 excised patient calcium plaques inserted was used for both a linear and a logistic regression analysis. An IRB approved in vivo prospective study of six patients was also performed to be used for logistic regression analysis. The threshold found by logistic regression model to define the calcium burden on virtual noncontrast images detects the calcium carrying potential risk for adverse coronary events correctly (2.45% error rate). DECT calcium mass and volume scores obtained by using the threshold correlates with both conventional Agatston and volume scores . A conventional CT cardiac exam requires two scans, including a noncontrast scan for calcium quantification and a contrast‐enhanced scan for coronary angiography. With the ability to quantify calcium on DECT contrast‐enhanced images, a DECT cardiac exam could be accomplished with one contrast‐enhanced scan for both calcium quantification and coronary angiography.PACS numbers: 87.57.Q, 87.57.N
Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
Caviness, John N., Beach, Thomas G. , Hentz, Joseph G. , Shill, Holly A. , Driver‐Dunckley, Erika , Driver-Dunckley, Erika D., Adler, Charles H.

Clinical EEG and Neuroscience | February 27, 2017 | Volume: 49 | Issue: 5 | Pages: 321-327

10.1177/1550059417696179 | PMID 29161906 Get It

Introduction. The key mechanisms that connect Parkinson’s disease pathology with dementia are unclear. We tested the hypothesis that the quantitative spectral electroencephalographic measure, delta bandpower, correlates with Lewy type synucleinopathy on pathological examination in Parkinson’s disease. As a corollary hypothesis, we analyzed whether there would be delta bandpower electroencephalographic differences between Parkinson’s disease dementia cases with and without pathological criteria for Alzheimer’s disease. Methods. We used pathological examination results from 44 Parkinson’s disease subjects from our brain bank with various degrees of cognitive decline, who had undergone electroencephalography. Pathological grading for Lewy type synucleinopathy, plaques, tangles, and indications of vascular pathology in subcortical and cortical areas were correlated with the most associated electroencephalographic biomarker with Parkinson’s disease dementia in our laboratory, delta bandpower. Group differences for all spectral electroencephalographic measures were also analyzed between cases with and without pathological criteria for Alzheimer’s disease. Results. Findings revealed significant correlations between delta bandpower with Lewy type synucleinopathy, whereas indications of Alzheimer’s disease or vascular pathology had nonsignificant correlation. The strongest association was with delta bandpower and Lewy type synucleinopathy in the anterior cingulate region. Mean delta bandpower was higher in the group for Parkinson’s disease dementia with Alzheimer’s disease pathology criteria than without. Conclusions. Lewy type synucleinopathy severity appears to be more associated with increased delta bandpower than with Alzheimer’s disease pathology or indications of vascular pathology over all cases. However, the presence of Alzheimer’s pathology may associate with more cortex physiological disruption in a subset of cases.
Using four‐dimensional computed tomography images to optimize the internal target volume when using volume‐modulated arc therapy to treat moving targets
Yakoumakis, N., Winey, Brian , Killoran, Joseph H., Mayo, Charles S. , Niedermayr, Thomas, Panayiotakis, George , Lingos, Tania, Court, Laurence E. , Mayo, Charles S.

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 13 | Issue: 6 | Pages: 181-188

10.1120/jacmp.v13i6.3850 | PMID 23149778 Get It

In this work we used 4D dose calculations, which include the effects of shape deformations, to investigate an alternative approach to creating the ITV. We hypothesized that instead of needing images from all the breathing phases in the 4D CT dataset to create the outer envelope used for treatment planning, it is possible to exclude images from the phases closest to the inhale phase. We used 4D CT images from 10 patients with lung cancer. For each patient, we drew a gross tumor volume on the exhale‐phase image and propagated this to the images from other phases in the 4D CT dataset using commercial image registration software. We created four different ITVs using the N phases closest to the exhale phase (where , 8, 7, 6). For each ITV contour, we created a volume‐modulated arc therapy plan on the exhale‐phase CT and normalized it so that the prescribed dose covered at least 95% of the ITV. Each plan was applied to CT images from each CT phase (phases 1–10), and the calculated doses were then mapped to the exhale phase using deformable registration. The effect of the motion was quantified using the dose to 95% of the target on the exhale phase and tumor control probability. For the three‐dimensional and 4D dose calculations of the plan where , differences in the value varied from 3% to 14%, with an average difference of 7%. For 9 of the 10 patients, the reduction in was less than 5% if eight phases were used to create the ITV. For three of the 10 patients, the reduction in the was less than 5% if seven phases were used to create the ITV. We were unsuccessful in creating a general rule that could be used to create the ITV. Some reduction (8/10 phases) was possible for most, but not all, of the patients, and the ITV reduction was small.PACS number: 87.55.D‐
Book Review
McLemore, Luke B.

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 12 | Issue: 1 | Pages: 239-240

10.1120/jacmp.v12i1.3428 Get It

The Checklist Manifesto: How to Get Things Right by Atul Gawande, M.D. Metropolitan Books, Henry Hold and Company, LLC, 2009, ISBN 978‐0‐8050‐9174‐8
Systematic offset of kV and MV localization systems as a function of gantry angle
Mullins, John, Herman, Michael , Mullins, John P

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 12 | Issue: 1 | Pages: 122-128

10.1120/jacmp.v12i1.3314 | PMID 21330978 Get It

Mechanical flex of the gantry and mounted imaging panels leads to systematic offsets in localization image isocenter as a function of gantry angle for linear accelerator‐mounted image guidance systems. Subsequently, object positions obtained from localization radiographs may be offset, resulting in greater target positioning uncertainty. While current QA procedures measure kV/MV image agreement, these measurements do not provide insight to apparent isocenter position for either single imaging system as a function of gantry rotation. This study measures offset as a function of gantry angle in kV and MV imaging systems on four treatment machines to investigate the magnitude of systematic offsets and their reproducibility between systems and machines, as well as over time. It is shown that each machine and energy has a reproducible pattern of offset as a function of gantry angle that is independent of kV/MV agreement, and it varies by machine. kV and MV offset ranges are on the order of 1.5 mm in the R/L and A/P directions, and 0.5 mm in the S/I direction. Variability of kV‐MV agreement is on the order of 0.7 mm. At certain angles, combinations of localization images could show a compounded offset of over 2 mm, exceeding the desired certainty threshold. Since these trends are persistent over time for each machine, online correction for image offsets as a function of gantry angle could improve the margin of positioning uncertainty.PACS number: 87.55.Qr
A static multi‐slit collimator system for scatter reduction in cone‐beam CT
Jang, Doh-Yun, Suh, Tae Suk , Chang, Jina , Kim, Siyong

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 11 | Issue: 4 | Pages: 196-205

10.1120/jacmp.v11i4.3269 | PMID 21081885 Get It

A multiple‐slit collimator (MSC) design was introduced for scatter reduction in cone‐beam computed tomography (CBCT). Unlike most other collimators, the open and closed septa of the proposed MSC are placed in an equi‐angular interval on a circular track of the central sagittal plane. Therefore, one gantry rotation provides only the half of necessary dataset and two gantry rotations are needed to obtain full information. During the first gantry rotation, the MSC position relative to the source is fixed. For the second rotation, the MSC is rotated by the equi‐angle interval. We assume signals under the closed septa are totally attributed to scatter radiation. Then, scatter contributions under open septa are determined by interpolating them.Monte Carlo (MC) simulations for two virtual phantoms (one with a simple geometry and the other with two heterogeneities simulating the bone and the lung) were performed to evaluate the effectiveness of the system. Using the method developed, we could obtain images with significant scatter reduction. Contrast ratio (CR) improvement factors were 1.165 in a 2D projection view, and 1.210 and 1.223 at the central and peripheral slice of the reconstructed CBCT image of the simple geometry phantom.This preliminary study demonstrated that the proposed MSC, together with the imaging process technique, had a great potential to reduce scatter contribution in CBCT. Further studies will be performed to investigate the effect of various factors, such as reducing the detector size, increasing the number of history of MC simulation, and including many structures with different densities.PACS number: 87.57.C
Guest Editorial: Patient safety and errors in the application of medical radiation: our responsibility
Herman, Michael

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 11 | Issue: 2 | Pages: 2-4

10.1120/jacmp.v11i2.3329 | PMID 20592707 Get It

An organ and effective dose study of XVI and OBI cone‐beam CT systems
Hyer, Daniel E. , Serago, Christopher F., Li, Jonathan G. , Hintenlang, David E., Kim, Siyong , Hyer, Daniel

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 11 | Issue: 2 | Pages: 181-197

10.1120/jacmp.v11i2.3183 | PMID 20592702 Get It

The main purpose of this work was to quantify patient organ doses from the two kilovoltage cone beam computed tomography (CBCT) systems currently available on medical linear accelerators, namely the X‐ray Volumetric Imager (XVI, Elekta Oncology Systems) and the On‐Board Imager (OBI, Varian Medical Systems). Organ dose measurements were performed using a fiber‐optic coupled (FOC) dosimetry system along with an adult male anthropomorphic phantom for three different clinically relevant scan sites: head, chest, and pelvis. The FOC dosimeter was previously characterized at diagnostic energies by Hyer et al. [Med Phys 2009;36(5):1711–16] and a total uncertainty of approximately 4% was found for in‐phantom dose measurements. All scans were performed using current manufacturer‐installed clinical protocols and appropriate bow‐tie filters. A comparison of image quality between these manufacturer‐installed protocols was also performed using a Catphan 440 image quality phantom. Results indicated that for the XVI, the dose to the lens of the eye (1.07 mGy) was highest in a head scan, thyroid dose (19.24 mGy) was highest in a chest scan, and gonad dose (29 mGy) was highest in a pelvis scan. For the OBI, brain dose (3.01 mGy) was highest in a head scan, breast dose (5.34 mGy) was highest in a chest scan, and gonad dose (34.61 mGy) was highest in a pelvis scan. Image quality measurements demonstrated that the OBI provided superior image quality for all protocols, with both better spatial resolution and low‐contrast detectability. The measured organ doses were also used to calculate a reference male effective dose to allow further comparison of the two machines and imaging protocols. The head, chest, and pelvis scans yielded effective doses of 0.04, 7.15, and 3.73 mSv for the XVI, and 0.12, 1.82, and 4.34 mSv for the OBI, respectively.PACS number: 87.57.uq
An anthropomorphic beating heart phantom for cardiac X‐ray CT imaging evaluation
Boltz, Thomas, Pavlicek, William , Paden, Robert G., Renno, Markus S. , Jensen, Angela , Akay, Metin

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 11 | Issue: 1 | Pages: 191-199

10.1120/jacmp.v11i1.3129 | PMID 20160697 Get It

The current work describes an anthropomorphic beating heart phantom constructed as a tool for the assessment of technological advances in cardiac X‐ray computed tomography (CT). The phantom is comprised of a thorax, a compressor system, an ECG system, a beating heart with tortuous coronary arteries, and the option to add or remove pathologies such as aberrant beats, stents, and plaques. Initial trials with the phantom have shown its utility to assess temporal resolution, spatial resolution, radiation dose, iodine contrast, stents, and plaques.PACS numbers: 87.59.Fm, 87.57.Ce
Calculating percent depth dose with the electron pencil‐beam redefinition algorithm
Price, Michael , Hogstrom, Kenneth R., White, R. Allen, Bloch, C. , Boyd, Robert A., Antolak, John A.

Journal of Applied Clinical Medical Physics | February 27, 2017 | Volume: 8 | Issue: 2 | Pages: 61-75

10.1120/jacmp.v8i2.2443 | PMID 17592466 Get It

In the present work, we investigated the accuracy of the electron pencil‐beam redefinition algorithm (PBRA) in calculating central‐axis percent depth dose in water for rectangular fields. The PBRA energy correction factor C(E) was determined so that PBRA‐calculated percent depth dose best matched the percent depth dose measured in water. The hypothesis tested was that a method can be implemented into the PBRA that will enable the algorithm to calculate central‐axis percent depth dose in water at a 100‐cm source‐to‐surface distance (SSD) with an accuracy of 2% or 1‐mm distance to agreement for rectangular field sizes cm. Preliminary investigations showed that C(E), determined using a single percent depth dose for a large field (that is, having side‐scatter equilibrium), was insufficient for the PBRA to accurately calculate percent depth dose for all square fields cm. Therefore, two alternative methods for determining C(E) were investigated. In Method 1, C(E), modeled as a polynomial in energy, was determined by fitting the PBRA calculations to individual rectangular‐field percent depth doses. In Method 2, C(E) for square fields, described by a polynomial in both energy and side of square W [that is, ], was determined by fitting the PBRA calculations to measured percent depth dose for a small number of square fields. Using the function C(E, W), C(E) for other square fields was determined, and C(E) for rectangular field sizes was determined using the geometric mean of C(E) for the two measured square fields of the dimension of the rectangle (square root method). Using both methods, PBRA calculations were evaluated by comparison with measured square‐field and derived rectangular‐field percent depth doses at 100‐cm SSD for the Siemens Primus radiotherapy accelerator equipped with a ‐cm applicator at 10 MeV and 15 MeV. To improve the fit of C(E) and C(E, W) to the electron component of percent depth dose, it was necessary to modify the PBRA's photon depth dose model to include dose buildup. Results showed that, using both methods, the PBRA was able to predict percent depth dose within criteria for all square and rectangular fields. Results showed that second‐ or third‐order polynomials in energy (Methods 1 and 2) and in field size (Method 2) were typically required. Although the time for dose calculation using Method 1 is approximately twice that using Method 2, we recommend that Method 1 be used for clinical implementation of the PBRA because it is more accurate (most measured depth doses predicted within approximately 1%) and simpler to implement.PACS number: 87.53.Fs